¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø ½Å°æ¿Ü°ú ¹Ú°ü·È«½Âö·±èÀº»ó ±³¼ö°¡ Áö³´Þ 16ÀϺÎÅÍ 21ÀÏ ¹Ì±¹ »÷ÇÁ¶õ½Ã½ºÄÚ¿¡¼ °³ÃÖµÈ Á¦60Â÷ ¹Ì±¹½Å°æ¿Ü°úÇÐȸ(Congress of Neurological Surgeons)¿¡ ÃÊû¹Þ¾Æ ¹ßÇ¥Çß´Ù°í 9ÀÏ ¹àÇû´Ù.
¶ÇÇÑ 25ÀÏ ÀϺ» ÈÄÄí¿ÀÄ«¿¡¼ Á¦69Â÷ ÀϺ»½Å°æ¿Ü°úÇÐȸ¿Í ÇÕµ¿À¸·Î °³ÃÖµÈ Japan-Asia Friendship Conference¿¡ ±èÁ¾Çö ±³¼ö´Â ÁÂÀåÀ¸·Î Âü¿©, ¹Ú°ü ±³¼ö´Â ‘¹Ì¼¼Ç÷°ü°¨¾Ð¼ú 1500·Ê¿¡ °üÇÑ °æÇè’, È«½Âö ±³¼ö´Â ‘¹ÌÆÄ¿¼º ³úµ¿¸Æ·ùÀÇ Ä¡·á’¿¡ ´ëÇØ Æ¯°À» ÁøÇàÇß´Ù.
ÀÌ¿Ü¿¡µµ ½Å°æ¿Ü°ú °øµÎ½Ä·³²µµÇö ±³¼öÆÀÀº 10¿ù 13ÀϺÎÅÍ 16ÀϱîÁö ¿¸° ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦50Â÷ Ãß°èÇмú´ëȸ¿¡¼ Neuro-oncology(2010) Àú³Î¿¡ ½Ç¸° ‘Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma’ ³í¹®ÀÌ ÃÖ¿ì¼ö ³í¹®À¸·Î ¼±Á¤µÅ Çмú»óÀ» ¼ö»óÇß´Ù.